Alnylam Pharmaceuticals (ALNY)

Add to Watchlists
Create an Alert
70.88 -4.91  -6.48% NASDAQ Aug 24, 16:59 Delayed 2m USD

Alnylam Pharmaceuticals Net Income (Quarterly):

-90.13M for June 30, 2016
View 4,000+ financial data types
Browse...
View Full Chart

Alnylam Pharmaceuticals Net Income (Quarterly) Chart

Export Data
Save Image

Alnylam Pharmaceuticals Historical Net Income (Quarterly) Data

View and export this data going back to 2003. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2016 -90.13M
March 31, 2016 -102.97M
Dec. 31, 2015 -90.72M
Sept. 30, 2015 -76.79M
June 30, 2015 -71.78M
March 31, 2015 -50.78M
Dec. 31, 2014 -21.39M
Sept. 30, 2014 -43.99M
June 30, 2014 -44.07M
March 31, 2014 -250.94M
Dec. 31, 2013 -32.36M
Sept. 30, 2013 -29.69M
June 30, 2013 -18.17M
March 31, 2013 -9.013M
Dec. 31, 2012 -62.19M
Sept. 30, 2012 -19.50M
June 30, 2012 -12.96M
March 31, 2012 -11.37M
Dec. 31, 2011 -14.30M
Sept. 30, 2011 -13.24M
June 30, 2011 -13.82M
March 31, 2011 -16.28M
Dec. 31, 2010 -6.93M
Sept. 30, 2010 -9.63M
June 30, 2010 -14.63M
   
March 31, 2010 -12.32M
Dec. 31, 2009 -7.791M
Sept. 30, 2009 -9.208M
June 30, 2009 -22.70M
March 31, 2009 -7.889M
Dec. 31, 2008 -9.392M
Sept. 30, 2008 -2.858M
June 30, 2008 -12.76M
March 31, 2008 -1.239M
Dec. 31, 2007 1.662M
Sept. 30, 2007 -52.79M
June 30, 2007 -12.69M
March 31, 2007 -21.64M
Dec. 31, 2006 -8.438M
Sept. 30, 2006 -7.40M
June 30, 2006 -9.91M
March 31, 2006 -8.86M
Dec. 31, 2005 -14.49M
Sept. 30, 2005 -10.68M
June 30, 2005 -11.14M
March 31, 2005 -6.60M
Dec. 31, 2004 -5.70M
Sept. 30, 2004 -6.416M
June 30, 2004 -6.956M
March 31, 2004 -13.58M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Net Income

Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More

Advertisement

ALNY Net Income (Quarterly) Benchmarks

Companies
Ionis Pharmaceuticals -56.86M
United Therapeutics 206.10M
ACADIA Pharmaceuticals -71.32M

ALNY Net Income (Quarterly) Range, Past 5 Years

Minimum -250.94M Mar 2014
Maximum -9.013M Mar 2013
Average -53.32M

ALNY Net Income (Quarterly) Excel Add-In Codes

  • Metric Code: net_income
  • Latest data point: =YCP("ALNY", "net_income")
  • Last 5 data points: =YCS("ALNY", "net_income", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.